Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP

Aideen Ryan

Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP

Aideen Ryan

Pharmacology

Research output: Chapter in Book or Conference Publication/Proceeding › Conference Publication › peer-review

Original language	English (Ireland)
Title of host publication	Blood
Place of Publication	10.1182/blood.V130.Suppl_1.121.121
Publication status	Published - 1 Dec 2017

Authors (Note for portal: view the doc link for the full list of authors)

Authors
Naicker S, Rigalou A, McEllistrim C, Natoni A, Chiu C, Sasser K, Ryan A, ODwyer M

Cite this

@inproceedings{c7d2845503ca48cfb0d69dac682dd256,

title = "Patient Data Supports the Rationale of Low Dose Cyclophosphamide to Potentiate the Anti-Myeloma Activity of Daratumumab through Augmentation of Macrophage-Induced ADCP",

author = "Aideen Ryan",

year = "2017",

month = dec,

day = "1",

language = "English (Ireland)",

booktitle = "Blood",

}